SOURCE: Endo Pharmaceuticals

December 20, 2006 16:15 ET

Endo Pharmaceuticals' CEO to Present at JP Morgan Healthcare Conference

Endo to Announce 2007 Financial Guidance in Early January

CHADDS FORD, PA -- (MARKET WIRE) -- December 20, 2006 -- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) announced today that President and Chief Executive Officer Peter A. Lankau will present at the JP Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco at 2:00 p.m. PST on Tuesday, January 9, 2007.

A live audio broadcast of the presentation can be accessed on Endo Pharmaceuticals' web site,, in the Investor Relations section. A replay will be available until January 31, 2007, and can be accessed at the same web address.

Separately, the company said it will issue a press release and hold a conference call regarding its 2007 financial guidance in early January prior to the JP Morgan Conference. Further details, including the date and time of release and conference call dial-in information, will be forthcoming.

About Endo

Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of both branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at

Contact Information

    Bill Newbould
    (610) 558-9800